Human Umbilical Cord Blood Mononuclear Cells Ameliorate CCl4-Induced Acute Liver Injury in Mice via Inhibiting Inflammatory Responses and Upregulating Peripheral Interleukin-22

Human Umbilical Cord Blood Mononuclear Cells Ameliorate CCl4-Induced Acute Liver Injury in Mice via Inhibiting Inflammatory Responses and Upregulating Peripheral Interleukin-22

Background: Human umbilical cord blood mononuclear cells (hUCBMNCs) show therapeutic effects on many inflammatory diseases. The deterioration of acute liver injury is attributed to excessive inflammatory responses triggered by damage-associated molecular patterns (DAMPs) and pathogen-associated mole...

Full description

Bibliographic Details
Main Authors:	Jinming Zhang, Hengben Zhai, Pei Yu, Dabao Shang, Ruidong Mo, Ziqiang Li, Xiaolin Wang, Jie Lu, Qing Xie, Xiaogang Xiang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Pharmacology
Subjects:	cell therapy liver injury liver inflammation liver regeneration IL-22
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.924464/full

Similar Items

The progress to establish optimal animal models for the study of acute-on-chronic liver failure
by: Hengben Zhai, et al.
Published: (2023-02-01)

Clinical characteristics and pathogen spectra of parasitic infections in a tertiary hospital of Shanghai: A 13-year retrospective study
by: Jinming Zhang, et al.
Published: (2022-09-01)

Genetic Variations of ALDH (rs671) Are Associated With the Persistence of HBV Infection Among the Chinese Han Population
by: Dabao Shang, et al.
Published: (2022-02-01)

Serum CCL22 Increased in Advanced Melanoma Patients with Liver Metastases: Report of 5 Cases
by: Kentaro Ohuchi, et al.
Published: (2022-12-01)

CD4+ T cell-derived IL-22 enhances liver metastasis by promoting angiogenesis
by: Tao Zhang, et al.
Published: (2023-12-01)

Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study
by: Kronenberger Bernd, et al.
Published: (2012-09-01)

The liver in biology and disease /
by: Bitter, Edward E.
Published: (2004)

Association of Cholecystectomy With Liver Fibrosis and Cirrhosis Among Adults in the USA: A Population-Based Propensity Score-Matched Study
by: Zhi-Qin Xie, et al.
Published: (2021-11-01)

COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status
by: Zhujun Cao, et al.
Published: (2022-05-01)

Celastrol: An Update on Its Hepatoprotective Properties and the Linked Molecular Mechanisms
by: Mengzhen Li, et al.
Published: (2022-04-01)

Prediction of hepatic metastasis and relapse in colorectal cancers based on concordance analyses with liver fibrosis scores
by: Xiang Hu, et al.
Published: (2020-02-01)

Association of Serum Vitamin C With NAFLD and MAFLD Among Adults in the United States
by: Zhi-Qin Xie, et al.
Published: (2022-02-01)

Clinical dilemmas in primary liver cancer /
by: Williams, Roger, 1931- 534528, et al.
Published: (2012)

Advances in decompensated cirrhosis treatment by human serum albumin
by: ZHANG Chenxi, et al.
Published: (2023-01-01)

Imbalance of mitochondrial fusion in peripheral blood mononuclear cells is associated with liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis
by: Thanaput Kunlayawutipong, et al.
Published: (2024-03-01)

Foxp3+ Regulatory T Cells Inhibit CCl4-Induced Liver Inflammation and Fibrosis by Regulating Tissue Cellular Immunity
by: Yoshinobu Ikeno, et al.
Published: (2020-10-01)

Long Non-coding RNA NEAT1 Alleviates Acute-on-Chronic Liver Failure Through Blocking TRAF6 Mediated Inflammatory Response
by: Yumin Xu, et al.
Published: (2019-12-01)

Sex-Dependent Hepatoprotective Role of IL-22 Receptor Signaling in Non-Alcoholic Fatty Liver Disease-Related FibrosisSummary
by: Mohamed N. Abdelnabi, et al.
Published: (2022-01-01)

Editorial: Acute-on-chronic liver failure: systemic inflammation and immunosuppression
by: Olaf Tyc, et al.
Published: (2023-08-01)

Drugs and the liver : a guide to drug handling in liver dysfunction /
by: North-Lewis, Penny
Published: (2008)

MicroRNAs as critical regulators in liver fibrosis
by: Xiaolin Wang, et al.
Published: (2023-09-01)

Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1/Stat3 signaling
by: Yulin He, et al.
Published: (2021-07-01)

Hepatoprotective Effects of Fumaria parviflora L. on CCl4–induced hepatotoxicity
by: A Jamshidzadeh, et al.
Published: (2006-09-01)

Tamoxifen Ameliorates Cholestatic Liver Fibrosis in Mice: Upregulation of TGFβ and IL6 Is a Potential Protective Mechanism
by: Dino Šisl, et al.
Published: (2022-05-01)

Assessing whether serum ceruloplasmin promotes non-alcoholic steatohepatitis via regulating iron metabolism
by: Xia Ziqiang, et al.
Published: (2023-01-01)

Effect of Gypenosides on the composition of gut microbiota and metabolic activity in the treatment of CCl4-induced liver injury in rats
by: Pengyao Tian, et al.
Published: (2022-10-01)

Heparanase Expression Propagates Liver Damage in CCL4-Induced Mouse Model
by: Xiaowen Cheng, et al.
Published: (2022-06-01)

Hyperuricemia Is Associated with Significant Liver Fibrosis in Subjects with Nonalcoholic Fatty Liver Disease, but Not in Subjects without It
by: Pei-Chia Yen, et al.
Published: (2022-03-01)

Liver as sole content of umbilical cord hernia
by: Zahra Almatar, et al.
Published: (2021-02-01)

Silymarin for Treating Toxic Liver Disease: International Consensus Recommendations
by: Anton Gillessen, MD, et al.
Published: (2022-01-01)

Transplantation for EASL-CLIF and APASL acute-on-chronic liver failure (ACLF) patients: The TEA cohort to evaluate long-term post-Transplant outcomes
by: Lei Xia, et al.
Published: (2022-07-01)

Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients
by: Yan Huang, et al.
Published: (2022-01-01)

Therapeutic Opportunities of IL-22 in Non-Alcoholic Fatty Liver Disease: From Molecular Mechanisms to Clinical Applications
by: Wenjing Zai, et al.
Published: (2021-12-01)

NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective study
by: Renling Yao, et al.
Published: (2024-01-01)

Editorial: Liver transplantation for liver cancer in the era of transplant oncology: accurate diagnosis and treatment
by: Ze Xiang, et al.
Published: (2023-09-01)

Hepatic NF-kB-inducing kinase (NIK) suppresses mouse liver regeneration in acute and chronic liver diseases
by: Yi Xiong, et al.
Published: (2018-08-01)

Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a population-based study
by: Kanokwan Pinyopornpanish, et al.
Published: (2021-10-01)

Surgical Models of Liver Regeneration in Pigs: A Practical Review of the Literature for Researchers
by: Lorenzo Cinelli, et al.
Published: (2023-02-01)

Liver Transplantation for Unresectable Calcifying Nested Stromal Epithelial Tumor: Case Report With a 1-Year Follow-Up and Review of Literature
by: Emilia Kruk, et al.
Published: (2022-05-01)

An Incidental Discovery of the Intrathoracic Accessory Liver Lobe in a 72-Year-Old Man: Case Report and Literature Review
by: Aleksandra Polikarpova, et al.
Published: (2024-03-01)